ASND · NASDAQ
Ascendis Pharma A (ASND) Stock Price & Fundamentals
$422.77+1.30%+$5.41End-of-day price as of Oct 9, 2026
Sample prices
Prices on this page are generated sample data for development, not real market data, so market cap, P/E and dividend yield are illustrative too.
Ascendis Pharma A (ASND) closed at $422.77 on Oct 9, 2026, up 1.30% from the previous close of $417.36.
Share price, past year
1Y +36.39%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $422.77 |
| Sep 30, 2026 | $410.41 |
| Aug 31, 2026 | $414.21 |
| Jul 31, 2026 | $380.97 |
| Jun 30, 2026 | $364.84 |
| May 29, 2026 | $355.80 |
| Apr 30, 2026 | $349.57 |
| Mar 31, 2026 | $346.88 |
| Feb 27, 2026 | $323.10 |
| Jan 30, 2026 | $335.76 |
| Dec 31, 2025 | $345.60 |
| Nov 28, 2025 | $351.98 |
| Oct 31, 2025 | $328.23 |
Key statistics
- 52-week range
- $306.94 – $422.77
Financials
Ascendis Pharma A reports to the SEC in international accounting standards (IFRS), which Laurel doesn't show yet.
Company profile
- Name
- Ascendis Pharma A/S
- Ticker
- ASND
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- Tuborg Boulevard 12, Hellerup
- Incorporated in
- G7
- Fiscal year ends
- December
- SEC CIK
- 0001612042
Frequently asked questions
What is Ascendis Pharma A's stock price?
Ascendis Pharma A (ASND) closed at $422.77 on Oct 9, 2026, up 1.30% from the previous close of $417.36.
Sources and methodology
Fundamentals come from Ascendis Pharma A/S's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures